Lanean...
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial
BACKGROUND: Early pregnancy loss (EPL) is a common event in the first trimester, occurring in 15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL management uses the prostaglandin E1 analogue misoprostol 800 mcg self-administered vaginally. The clinical utility of this...
Gorde:
| Argitaratua izan da: | Am J Obstet Gynecol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529708/ https://ncbi.nlm.nih.gov/pubmed/32305259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.04.006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|